Skip to content

Plaque Removal Versus Open Bypass Surgery For Critical Limb Ischemia

Plaque Removal Versus Open Bypass Surgery For Critical Limb Ischemia

Status
Terminated
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00504088
Acronym
PROOF
Enrollment
Unknown
Registered
2007-07-19
Start date
2006-10-31
Completion date
Unknown
Last updated
2008-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral Vascular Diseases

Keywords

CLI, Critical Limb Ischemia, PAD, Peripheral Arterial Disease, Artherosclerosis, Leg Pain, Cardiovascular, Artherectomy, Bypass, Peripheral Bypass, PROOF

Brief summary

To compare the outcome of bypass surgery and plaque excision for treatment of critical limb ischemia in the lower limbs

Interventions

PROCEDUREBypass
PROCEDURESilverhawk Plaque Excision

Sponsors

FoxHollow Technologies
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Ischemic rest pain for more than 2 weeks or ulceration or gangrene of the foot or toes (Rutherford Becker Category 4, 5 or 6) * Willing and able, as evaluated by the PI, to provide Informed Consent * Willing to undergo up to 5 years of clinical follow up visits as scheduled * Angiographic pattern of infrainguinal disease that can be reasonably managed either by surgery or plaque excision in the first instance * Reconstitution of at least one patent target tibial segment below the knee which provides run-off to the foot * The patient must be \>18 years of age * Target lesion(s) is located at or below the level of the superficial femoral artery * Target lesion(s) is \>50% stenosed by quantitative vascular angiography * Ability to take at least one of the following types of medications: anti- platelet or anti-thrombotic therapy

Exclusion criteria

* Patient has cardiac or cardiovascular comorbidities that would make surgery inappropriate * Patient has terminal or Stage 4 cancer * Patient has extensive gangrene that requires both a Below-the-Knee amputation and a revascularization procedure * Previous stent in the target lesion * Active infection at planned incision site * The patient is a pregnant woman * The patient has significant suprainguinal or Common Femoral disease that can not be treated either prior to or during the index procedure * Target Lesion is a Chronic Total Occlusion (CTO) that is greater than 15cm in length and has severe, continuous calcification

Design outcomes

Primary

MeasureTime frame
Major amputation-free survival

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026